135 related articles for article (PubMed ID: 2228319)
1. Oncogene expression of FANFT- or BBN-induced rat urothelial cells.
Debiec-Rychter M; Jones RF; Zukowski K; Wang CY
Int J Cancer; 1990 Nov; 46(5):913-8. PubMed ID: 2228319
[TBL] [Abstract][Full Text] [Related]
2. Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.
Jones RF; Debiec-Rychter M; Zukowski K; Wang CY
Mol Carcinog; 1990; 3(6):393-402. PubMed ID: 2278634
[TBL] [Abstract][Full Text] [Related]
3. Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea.
Masui T; Mann AM; Macatee TL; Garland EM; Okamura T; Smith RA; Cohen SM
Carcinogenesis; 1991 Oct; 12(10):1975-8. PubMed ID: 1682063
[TBL] [Abstract][Full Text] [Related]
4. Cell line specific abnormalities in expression of PNA, SBA and L-PHA binding sites by carcinogen induced rat urothelial carcinomas.
Rak JW; Debiec-Rychter M; Miller FR; Wang CY
Neoplasma; 1992; 39(3):141-6. PubMed ID: 1528317
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immunoreactivity of ras oncogene p21 protein in urinary bladder epithelium of rats treated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Masui T; Ward JM; Cohen SM
Cancer Lett; 1991 Aug; 59(2):95-102. PubMed ID: 1884376
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal characteristics and malignancy of urothelial cells from carcinogen-treated rats.
Debiec-Rychter M; Zukowski K; Wang CY
J Natl Cancer Inst; 1989 Mar; 81(5):361-7. PubMed ID: 2915372
[TBL] [Abstract][Full Text] [Related]
7. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
8. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
10. Neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide- induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells.
Mann AM; Asamoto M; Masui T; Macatee T; Eklund SH; Cohen SM
Cancer Lett; 1994 Aug; 84(1):7-13. PubMed ID: 7915640
[TBL] [Abstract][Full Text] [Related]
11. Effect of dose on the induction of urothelial proliferation by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and its relationship to bladder carcinogenesis in the rat.
Hasegawa R; Cohen SM; St John M; Cano M; Ellwein LB
Carcinogenesis; 1986 Apr; 7(4):633-6. PubMed ID: 3698195
[TBL] [Abstract][Full Text] [Related]
12. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.
Cohen SM; Tatematsu M; Shinohara Y; Nakanishi K; Ito N
J Natl Cancer Inst; 1980 Jul; 65(1):145-8. PubMed ID: 6930511
[TBL] [Abstract][Full Text] [Related]
13. Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin.
Masui T; Mann AM; Borgeson CD; Garland EM; Okamura T; Fujii H; Pelling JC; Cohen SM
Teratog Carcinog Mutagen; 1993; 13(5):225-33. PubMed ID: 7905676
[TBL] [Abstract][Full Text] [Related]
14. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
15. Mutation and altered expression of p53 genes in experimental rat bladder tumor cells.
Jones RF; Matuszyk J; Debiec-Rychter M; Wang CY
Mol Carcinog; 1994 Feb; 9(2):95-104. PubMed ID: 8142014
[TBL] [Abstract][Full Text] [Related]
16. In vitro transformation of rat bladder epithelium by 2-amino-4-(5-nitro-2-furyl)thiazole.
Mann AM; Masui T; Chlapowski FJ; Okamura T; Borgeson CD; Cohen SM
Carcinogenesis; 1991 Mar; 12(3):417-22. PubMed ID: 2009588
[TBL] [Abstract][Full Text] [Related]
17. Point mutation in codons 12 and 61 of the Ha-ras gene in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Masui T; Mann AM; Garland EM; Okamura T; Johansson PL; Cohen SM
Mol Carcinog; 1990; 3(4):210-5. PubMed ID: 2206284
[TBL] [Abstract][Full Text] [Related]
18. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
[TBL] [Abstract][Full Text] [Related]
19. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
20. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y
J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]